Psychiatr. pro Praxi, 2004; 5: 273-275

Postavenie lamotrigínu v liečbe bipolárnej depresie

MUDr. Lívia Vavrušová
Psychiatrická klinika SPAM FN Ružinov, Bratislava

Published: December 31, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vavrušová L. Postavenie lamotrigínu v liečbe bipolárnej depresie. Psychiatr. praxi. 2004;9(5):273-275.

Niektoré antiepileptiká (antikonvulzíva) sa stali významnými liekmi v liečbe bipolárnej poruchy ako tymprofylaktiká. Do skupiny antikonvulzív zaraďujeme lieky s rôznymi mechanizmami pôsobenia, účinnosti a vedľajších účinkov. Lamotrigín si našiel pevné miesto v liečbe bipolárnej depresie. Medzinárodná skupina vytvárajúca terapeutické doporučenia pre liečbu bipolárnej depresie potvrdila, že lamotrigín je liekom bipolárnej depresie s úrovňou dôkazov kategórie 1, čiže liekom s najlepším stupňom dôkazov účinnosti pre liečbu danej klinickej jednotky.

Kľúčové slová

antikonvulzíva, lamotrigín, bipolárna, depresia.

Download citation

References

  1. Schatzberg AF, Nemeroff CB, eds. Textbook of Psychiatry, 3rd ed. Washington DC, American Psychiatric Press, 2003.
  2. Gee NS, a kol. J. Biol. Cem. 1996; 271: 5768-5776. Go to original source...
  3. Stahl SM. Psychopharmacology of Anticolvunsants: Do all Anticonvulsants Have the same echanism of Action?, J. Clin. Psychiatry, February, 2004; 65, 2: 149-150. Go to original source... Go to PubMed...
  4. International Consensus Group on Bipolar I Depression Treatment Guidelines, J. Clinical Psychiatry, 2004; 65: 1-9. Go to original source...
  5. Calabrese JR, Bowden CL, Sachs GS, a. kol. A double blind placebo controlled study of lamotrigine monotherapy in outpatients with bipolar I depression., J.Clin. Psychiatry, 1999; 60: 79-88. Go to original source... Go to PubMed...
  6. Calabrese JR, Bowden CL, Sachs G, a kol. A placebo controlled 18 month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar disorder., J. Clin. Psych., 2003; 64: 1013-1024. Go to original source... Go to PubMed...
  7. White HS. J. Clin. Psychiatry, 2003; 64 (Suppl. 8): 5-8. Go to original source...
  8. Tohen M, Vieta E, Calabrese J, a kol. Efficacy of olanzapine and olanzapine - fluoxetine combination in the treatment of bipolar I depression. Arch. Gen. Psychiatry, 2003; 60: 1079-1088. Go to original source... Go to PubMed...
  9. Vavrušová L. Bipolárna depresia In: Vavrušová L. ed. Bipolárna porucha, Vydavateľstvo Osveta, Martin, 2004: 194-204.
  10. Češková E. Antikonvulziva v psychiatrii In Vavrušová L. ed. Bipolárna porucha, Vydavateľstvo Osveta, Martin, 2004; 114-129.




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.